Bright Minds Biosciences Cash Flow Statement (2020-2025) | DRUG

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-1.09M-1.24M0.17M0.04M
Cash from Operations (Quarter)
1.11M2.42M-9.73M3.93M2.88M2.24M-19.20M1.96M1.12M1.23M-9.59M0.60M0.60M-0.18M-2.37M1.07M-3.77M-2.53M-0.92M-4.17M
Depreciation, Depletion & Amortization
Amortization (Quarter)
15.92M12.23M9.29M6.92M9.16M8.42M7.31M6.24M5.08M5.02M4.82M4.58M4.39M0.17M39.25M0.12M61.26M65.10M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M-0.02M0.05M0.02M0.02M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
0.03M-0.04M
Change in Accured Expenses (Quarter)
0.00M0.00M0.00M0.00M0.00M-176.940.00M0.01M0.01M0.00M
Investing Activities
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)
-0.02M0.06M-0.12M-0.38M
Cash from Financing Activities (Quarter)
19.53M-0.44M-0.01M0.09M0.00M0.01M3.88M1.66M-0.02M-0.02M-0.02M0.64M-0.02M-0.02M-0.02M37.25M0.16M-0.01M24.21M9.60M
Additional items
Exchange Rate Effect (Quarter)
0.01M0.06M0.12M0.15M-0.01M0.02M0.04M0.01M0.00M0.08M-0.12M-0.03M-0.00M0.03M0.01M1.17M-0.01M-0.56M-0.38M-1.03M
Change in Cash (Quarter)
18.43M-2.86M-1.91M3.83M2.88M2.24M-15.12M-0.30M1.74M1.24M-6.30M0.04M-0.61M0.16M-0.36M36.18M-1.53M-2.54M23.29M5.43M
Free Cash Flow (Quarter)
1.11M2.42M-9.73M3.93M2.88M2.24M-19.20M1.96M1.12M1.23M-9.59M0.60M0.60M-0.18M-2.37M1.07M-3.77M-2.53M-0.92M-4.17M
Net Cash Flow (Quarter)
20.64M1.97M-9.74M4.02M2.88M2.25M-15.32M3.62M1.10M1.21M-9.60M1.25M0.58M-0.19M-2.39M38.32M-3.62M-2.54M23.29M5.43M